These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 9873175)

  • 21. Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long study.
    Gits-Muselli M; Benderdouche M; Hamane S; Mingui A; Feuilhade de Chauvin M; Guigue N; Picat MQ; Bourrat E; Petit A; Bagot M; Alanio A; Bretagne S
    Med Mycol; 2017 Jul; 55(5):476-484. PubMed ID: 27744309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tinea capitis in children: a systematic review of management.
    Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tinea capitis in adults in southern Spain. A 17-year epidemiological study.
    Lova-Navarro M; Gómez-Moyano E; Martínez Pilar L; Fernandez-Ballesteros MD; Godoy-Díaz DJ; Vera-Casaño A; Crespo-Erchiga V
    Rev Iberoam Micol; 2016; 33(2):110-3. PubMed ID: 26774593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tinea capitis due to Microsporum audouinii in Malta.
    Vella Zahra L; Vella Briffa D
    Mycoses; 2003; 46(9-10):433-5. PubMed ID: 14622396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring treatment and antifungal resistance in an outbreak of tinea caused by Microsporum audouinii.
    Johansen CD; Shen JJR; Astvad KMT; Jemec GBE; Christensen JJ; Saunte DML
    Mycoses; 2024 Jul; 67(7):e13760. PubMed ID: 38943042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D
    Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of dermatophytes and their in-vitro antifungal sensitivity.
    Sumana MN; Rajagopal V
    Indian J Pathol Microbiol; 2002 Apr; 45(2):169-72. PubMed ID: 12696733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species distribution and antifungal susceptibilities of dermatophytes during a one year period at a university hospital in Turkey.
    Ozkutuk A; Ergon C; Yulug N
    Mycoses; 2007 Mar; 50(2):125-9. PubMed ID: 17305776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran.
    Ansari S; Hedayati MT; Zomorodian K; Pakshir K; Badali H; Rafiei A; Ravandeh M; Seyedmousavi S
    Mycopathologia; 2016 Feb; 181(1-2):89-95. PubMed ID: 26369643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rising menace of antifungal resistance in dermatophytes among the patients of tinea capitis.
    Zeeshan F; Sabir M; Uddin F
    J Pak Med Assoc; 2023 Jan; 73(1):43-48. PubMed ID: 36842005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of aminosterols against dermatophytes.
    Coulibaly O; Alhanout K; L'Ollivier C; Brunel JM; Thera MA; Djimdé AA; Doumbo OK; Piarroux R; Ranque S
    Med Mycol; 2013 Apr; 51(3):309-12. PubMed ID: 22998181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients.
    Deng S; de Hoog GS; Verweij PE; Zoll J; Ilkit M; Morsali F; Abliz P; Wang X; Zhan P; Yang L; Hasimu H; Liao W; Pan W; Seyedmousavi S
    J Antimicrob Chemother; 2015 Apr; 70(4):1072-5. PubMed ID: 25492394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of tinea capitis in Israel: A comparative study.
    Shemer A; Gupta AK; Galili E; Daniel R; Kassem R; Farhi R; Grunwald H; Bamimore MA
    Pediatr Dermatol; 2021 Jul; 38(4):806-811. PubMed ID: 33998709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis.
    Jahangir M; Hussain I; Ul Hasan M; Haroon TS
    Br J Dermatol; 1998 Oct; 139(4):672-4. PubMed ID: 9892912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New treatments for tinea capitis.
    Chan YC; Friedlander SF
    Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tinea Capitis by Microsporum canis in an Elderly Female with Extensive Dermatophyte Infection.
    Yang Z; Chen W; Wan Z; Song Y; Li R
    Mycopathologia; 2021 May; 186(2):299-305. PubMed ID: 33496917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tinea capitis].
    Fukuda T
    Med Mycol J; 2011; 52(1):7-13. PubMed ID: 21441707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.